What is the market doing?
What the tape says about NVO
Novo Nordisk A/S is +1.5% over the past year while the S&P 500 is +23%: 21 points behind the market.
+1.5%
1-year return · S&P 500 +23%
- vs 200-day average
- +3.5%
vs 200-day average · close to trend
- RSI (14)
- 56
RSI (14) · neutral
- Below its 52-week high
- −24%
Below its 52-week high
Details›
- Last close2026-08-26
- $47.19
- 1 monthS&P 500 +3.7%
- −2.1%
- 1 yearS&P 500 +23%
- +1.5%
- 5 yearsS&P 500 +87%
- +13%
- vs 50-day average$46.36
- +1.8%
- 52-week high
- $61.72
- 52-week low
- $34.76
- Annualised volatility
- 49%
| Year | Return |
|---|---|
| 2026 (year to date) | −3.9% |
| 2025 | −39% |
| 2024 | −16% |
| 2023 | +55% |
| 2022 | +23% |
| 2021 | +64% |
| 2020 | +23% |
| 2019 | +29% |
| 2018 | −12% |
| 2017 | +54% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +2.9% |
| Feb | 10 | 6 of 10 | −2.8% |
| Mar | 10 | 6 of 10 | +1.6% |
| Apr | 10 | 6 of 10 | +3.5% |
| May | 10 | 7 of 10 | +3.2% |
| Jun | 10 | 7 of 10 | +2.0% |
| Jul | 11 | 5 of 11 | −1.0% |
| Aug | 11 | 7 of 11 | +3.9% |
| Sep | 10 | 2 of 10 | −3.8% |
| Oct | 10 | 5 of 10 | −0.74% |
| Nov | 10 | 6 of 10 | +2.5% |
| Dec | 10 | 8 of 10 | +1.5% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - General
Ranks #4 of 16 by Smart Score